GLOW
Also Known As: GLOW stack, TB500 BPC157 GHK-Cu stack, TB-500 BPC-157 GHK-Cu blend, Skin regeneration stack, Beauty peptide stack, Anti-aging skin stack, Glow peptide blend, Cosmetic healing stack, Dermal regeneration stack, Skin healing triple stack, TB BPC GHK stack, beauty, collagen blend
GLOW is a research-grade Peptide stack: TB-500 + BPC-157 + GHK-Cu targeting Triple-pathway: actin sequestration/VEGF studied in Peptide Stacks research. It is supplied strictly for in vitro laboratory research use only - not for human or animal consumption, and not FDA-approved.
Evidence Tier: Research Compound - No approved human use; sold for laboratory research only.
A skin-and-recovery stack adding the copper peptide GHK-Cu to BPC and TB; banned in sport via TB-500.
At A Glance
| Category | Peptide Stacks |
|---|---|
| Compound Class | Peptide stack: TB-500 + BPC-157 + GHK-Cu |
| Molecular Target | Triple-pathway: actin sequestration/VEGF (TB-500) + NO/EGF/VEGF (BPC-157) + MMP/TGF-beta/antioxidant (GHK-Cu) |
| Molecular Weight | combination |
| Amino Acid Sequence | TB-500 + BPC-157 + GHK-Cu |
| CAS Number | n/a |
| Half-Life | ~30 hours (TB-500) / ~30 min (BPC-157) / ~5-10 min (GHK-Cu) |
| WADA Status | prohibited |
| Evidence Tier | Research Compound |
Mechanism Of Action
It merges three distinct pathways: BPC-157 fixes cellular damage, TB-500 drives cell migration to the skin, and GHK-Cu directly stimulates the production of collagen and elastin proteins.
Studied For
- Skin anti-aging / regeneration
- Wound healing acceleration
- Collagen and elastin synthesis
- Skin tightening and firmness
- Hair growth support
- Dermal tissue repair
- Wrinkle reduction
- Post-procedure skin recovery
- Scar minimization
- Angiogenesis for skin
- Combined systemic and local tissue repair
- Skin brightening
- Anti-inflammatory skin health
- Comprehensive cosmetic healing
- skin radiance
- anti-aging
- hair and nails
Reported Research Findings
No controlled human combination data; GHK-Cu human evidence is topical rather than injectable.
Safety And Handling Notes
Three pro-angiogenic agents stacked amplify the theoretical tumor-vascularization caveat; copper load and complex stability matter.
Contains TB-500 (WADA-prohibited); the rest are unapproved. Research use only.
Regulatory Status
Not FDA-approved; TB-500 WADA-prohibited.
Full Reference Detail
Related Research Guides
Maintained By The Pep Nation Lab Research Team. See Our Editorial Standards And Research Methodology For How This Reference Is Sourced And Reviewed.
This Reference Is Provided For In Vitro Laboratory Research Use Only. Not For Human Consumption. See The Full Research Disclaimer.